Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia;Prevalencia del VIH, hepatitis C y factores asociados en usuarios de drogas por vía parenteral seleccionados en Cataluña

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue 4, 2010, Pages 236-238

  Huntington, Susie ^a,b   Folch, Cinta ^a,c,d   González, Victoria ^a,c   Meroño, Mercè ^e   Ncube, Fortune ^b   Casabona, Jordi ^a,c,f  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d d'Obstetrícia i Ginecologia i de Medicina Preventiva   (Spain)

^e Àmbit Prevenció Foundation Ciutat Vella District   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Hepatitis C virus; HIV; Injecting drug users; Risk behavior

Indexed keywords

COCAINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SYRINGE;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; EQUIPMENT CONTAMINATION; FEMALE; HEPATITIS C; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; PRISONERS; RISK-TAKING; SOCIOECONOMIC FACTORS; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 77951294747     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2009.06.004     Document Type: Article

References (10)

1. Centro Nacional de Epidemiología. Registro Nacional de SIDA: vigilancia epidemiológica del SIDA en España. Informe semestral No. 2, 2006 (2006), Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid
2. De La Fuente L., Bravo M.J., Toro C., Brugal M.T., Barrio G., Soriano V., et al. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. J Epidemiol Community Health 60 (2006) 537-542
3. EuroHIV. HIV/AIDS surveillance in Europe. Mid-year report 2007 (2007), Institut de Veille Sanitaire, Saint-Maurice
4. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Sistema integrat de vigilància epidemiològica de Sida/VIH/ITS a Catalunya (SIVES): informe bianual (2008), Generalitat de Catalunya, Departament de Salut, Barcelona
5. Muga R., Sanvisens A., Bolao F., Tor J., Santesmases J., Pujol R., et al. Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. Drug Alcohol Depend 82 (2006) S29-S33
6. WHO Programme on Substance Abuse. Multi-city study on drug injecting and risk of HIV infection. Document: WHO/PSA/94.4 (1994), World Health Organisation, Geneva
7. Vallejo F., Toro C., Brugal M.T., De la Fuente L., Soriano V., Jiménez R., et al. Muy alta incidencia de VIH y VHC en jóvenes consumidores de heroína. Logroño: XXIV Reunión Científica Anual de la Sociedad Española de Epidemiología, octubre 2006. Gac Sanit 20 (2006) 130
8. Barrio G., De La F.L., Toro C., Brugal T.M., Soriano V., Gonzalez F., et al. Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: Gender differences and other related factors. Epidemiol Infect 135 (2007) 592-603
9. Maher L., Jalaludin B., Chant K.G., Jayasuriya R., Sladden T., Kaldor J.M., et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 101 (2006) 1499-1508
10. European Monitoring Centre for Drugs and Drug Addiction. 2008 Annual report: The state of the drugs problem in Europe (2008), EMCDDA, Lisboa